All people encounter, inhale, and ingest fungi on a daily basis. Although only several hundred of the estimated five million species of fungi worldwide cause disease in humans, advances in medical technologies and the global AIDS pandemic have dramatically increased our susceptibility to fungal disease.
Tobias M. Hohl, MD, PhD
Chief, Infectious Diseases Service
Research FocusPhysician-scientist Tobias Hohl studies the molecular pathogenesis of human fungal pathogens and how the immune system responds to them.
- MD, Weill Medical College of Cornell University
- PhD, Weill Graduate School of Medical Sciences of Cornell University
- Shlezinger N, Irmer I, Dhingra S, Beattie SR, Cramer RA, Braus GH, Sharon A, and Hohl TM. Sterilizing immunity in the lung relies on targeting fungal apoptosis-like programmed cell death. Science. 357:1037-1041.
- Kasahara S, Jhingran A, Dhingra S, Salem A, Cramer R, Hohl TM. Role of granulocyte-macrophage colony-stimulating factor signaling in regulating neutrophil antifungal activity and the oxidative burst during respiratory fungal challenge. J Infect Dis. 213:1289-1298, 2016.
- Investigator in the Pathogenesis of Infectious Diseases, Burrroughs Wellcome Fund (2014)
- Fellow, Infectious Diseases Society of America (2012)
- Young Investigator Award, American Society of Microbiology (2009)
- Member, American Society of Clinical Investigation (2016)